Pseudomonas aeruginosa bloodstream infection in patients with hematological diseases: Clinical outcomes and prediction model of multidrug-resistant infections

J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.08.037. Epub 2022 Sep 3.
No abstract available

Keywords: Antibiotic; Multidrug resistance; Outcome; Pseudomonas aeruginosa; Treatment.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Drug Resistance, Multiple, Bacterial
  • Hematologic Diseases* / complications
  • Humans
  • Microbial Sensitivity Tests
  • Pseudomonas Infections* / drug therapy
  • Pseudomonas aeruginosa
  • Sepsis* / drug therapy

Substances

  • Anti-Bacterial Agents